Stock Scorer

EXOSENS (EXENS.PA)

EXOSENS reported revenue of 468.2M EUR for the year ending 31 December 2025, up 22.1% from 383.4M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in EUR. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in EUR.
FigurePeriodAmountYear on year
Revenue 2025 · ending 31 December 2025 468.2M +22.1%
Operating Income 2025 · ending 31 December 2025 102M +32.9%
Net Income 2025 · ending 31 December 2025 42.7M +39.2%
Operating Cash Flow 2025 · ending 31 December 2025 107.3M +8.7%
EPS 2025 · ending 31 December 2025 0.84 +37.7%

Revenue and profit by financial year

As filed, in EUR. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 468.2M102M42.7M
20242024-12-31 383.4M76.8M30.7M
20232023-12-31 291.8M48.3M18.4M

Every period

Revenue Annual

PeriodEndingRevenue
FY252025-12-31468.2M
FY242024-12-31383.4M
FY232023-12-31291.8M

Operating Income Annual

PeriodEndingOperating Income
FY252025-12-31102M
FY242024-12-3176.8M
FY232023-12-3148.3M

Net Income Annual

PeriodEndingNet Income
FY252025-12-3142.7M
FY242024-12-3130.7M
FY232023-12-3118.4M

Operating Cash Flow Annual

PeriodEndingOperating Cash Flow
FY252025-12-31107.3M
FY242024-12-3198.7M
FY232023-12-3150.5M

EPS Annual

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
FY252025-12-310.84
FY242024-12-310.61
FY232023-12-310.24